Sign in to view content

Three-Year Outcomes of the PALADIN Phase IV Study: Comparison of Anatomical Metrics, Efficacy, and Treatment Burden Post FAc

Christopher D. Riemann, MD

Video
Published 2022

Related

Quantification of Capillary Nonperfusion in Diabetic Retinopathy Using Ultra-widefield Optical Coherence Tomography Angiography
Kasra Rezaei, M.D.
Annual Meeting Talks
2019
New Tool for Predicting the 3-Year Risk of Vision-Threatening Diabetic Retinopathy in Patients With Type 2 Diabetes Mellitus
Bobeck S Modjtahedi, MD
Annual Meeting Talks
2022
What Happens to Diabetic Retinopathy Severity Scores With Less Aggressive Treatment? A Post Hoc Analysis of the RISE and RIDE Open Label Extension Study
Roger A. Goldberg, MD, MBA
Updates from the Field
2019

Category: Diabetic Retinopathy

See more